Whilst the mutational testing of BRAF is recommended in the CRC clinical guidelines for prognostic stratification, and MMR status identification, findings suggest that BRAF mutation alone is insufficient for a full diagnosis of CRC [19]. Here, BRAF is linked to colorectal carcinoma.